;PMID: 10835530
;source_file_568.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..42] = [t:0..42]
;1)sentence:[e:47..166] = [t:47..166]
;2)section:[e:170..204] = [t:170..204]
;3)section:[e:208..314] = [t:208..314]
;4)sentence:[e:318..436] = [t:318..436]
;5)sentence:[e:437..708] = [t:437..708]
;6)sentence:[e:710..853] = [t:710..853]
;7)sentence:[e:854..1016] = [t:854..1016]
;8)sentence:[e:1017..1161] = [t:1017..1161]
;9)sentence:[e:1162..1299] = [t:1162..1299]
;10)sentence:[e:1300..1368] = [t:1300..1368]
;11)sentence:[e:1369..1496] = [t:1369..1496]
;12)sentence:[e:1497..1625] = [t:1497..1625]
;13)sentence:[e:1626..1770] = [t:1626..1770]
;14)sentence:[e:1771..1924] = [t:1771..1924]
;15)section:[e:1928..1973] = [t:1928..1973]

;section 0 Span:0..42
;Arch Pathol Lab Med  2000 Jun;124(6):894-7
(SEC
  (FRAG (NNP:[0..4] Arch) (NNP:[5..11] Pathol) (NNP:[12..15] Lab)
        (NNP:[16..19] Med) (CD:[21..25] 2000) (.:[26..32] Jun;12)
        (CD:[32..33] 4) (NN:[33..34] -LRB-) (NN:[34..35] 6) (NN:[35..36] -RRB-)
        (::[36..37] :) (CD:[37..39] 89) (CD:[39..42] 4-7)))

;sentence 1 Span:47..166
;Spindle cell tumor of urinary bladder serosa with phenotypic and genotypic 
;features of gastrointestinal stromal tumor.
;[47..91]:malignancy:"Spindle cell tumor of urinary bladder serosa"
;[135..165]:malignancy:"gastrointestinal stromal tumor"
(SENT
  (NP-HLN
    
    (NP (NN:[47..54] Spindle) (NN:[55..59] cell) (NN:[60..65] tumor))
    (PP (IN:[66..68] of)
      (NP (JJ:[69..76] urinary) (NN:[77..84] bladder) (NN:[85..91] serosa)))
    (PP (IN:[92..96] with)
      (NP
        (NP
          (NP (JJ:[97..107] phenotypic)
            (NML-1 (-NONE-:[107..107] *P*)))
          (CC:[108..111] and)
          (NP (JJ:[112..121] genotypic)
            (NML-1 (NNS:[123..131] features))))
        (PP (IN:[132..134] of)
          (NP (JJ:[135..151] gastrointestinal) (JJ:[152..159] stromal)
              (NN:[160..165] tumor)))))
    (.:[165..166] .)))

;section 2 Span:170..204
;Lasota J, Carlson JA, Miettinen M.
(SEC
  (FRAG (NNP:[170..176] Lasota) (NNP:[177..179] J,) (NNP:[180..187] Carlson)
        (NNP:[188..190] JA) (,:[190..191] ,) (NNP:[192..201] Miettinen)
        (NNP:[202..204] M.)))

;section 3 Span:208..314
;Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, 
;Washington, DC 20306-6000, USA.
(SEC
  (FRAG (NNP:[208..218] Department) (IN:[219..221] of) (NNP:[222..226] Soft)
        (NNP:[227..233] Tissue) (NNP:[234..243] Pathology) (,:[243..244] ,)
        (NNP:[245..250] Armed) (NNP:[251..257] Forces)
        (NNP:[258..267] Institute) (IN:[268..270] of) (NNP:[271..280] Pathology)
        (,:[280..281] ,) (NNP:[283..293] Washington) (,:[293..294] ,)
        (NNP:[295..297] DC) (CD:[298..302] 2030) (CD:[302..308] 6-6000)
        (,:[308..309] ,) (NNP:[310..313] USA) (.:[313..314] .)))

;sentence 4 Span:318..436
;Most mesenchymal tumors of the gastrointestinal tract are now referred to as 
;gastrointestinal stromal tumors (GISTs).
;[323..371]:malignancy:"mesenchymal tumors of the gastrointestinal tract"
;[396..427]:malignancy:"gastrointestinal stromal tumors"
;[429..434]:malignancy:"GISTs"
(SENT
  (S
    (NP-SBJ-1
      (NP (JJS:[318..322] Most) (JJ:[323..334] mesenchymal)
          (NNS:[335..341] tumors))
      (PP (IN:[342..344] of)
        (NP (DT:[345..348] the) (JJ:[349..365] gastrointestinal)
            (NN:[366..371] tract))))
    (VP (VBP:[372..375] are)
      (ADVP-TMP (RB:[376..379] now))
      (VP (VBN:[380..388] referred)
        (PP (TO:[389..391] to)
          (NP-1 (-NONE-:[391..391] *)))
        (PP (IN:[392..394] as)
          (NP
            (NP (JJ:[396..412] gastrointestinal) (JJ:[413..420] stromal)
                (NNS:[421..427] tumors))
            (NP (-LRB-:[428..429] -LRB-) (NNS:[429..434] GISTs)
                (-RRB-:[434..435] -RRB-))))))
    (.:[435..436] .)))

;sentence 5 Span:437..708
;The tumors differ from ordinary  leiomyomas and schwannomas in several
;respects: the GISTs typically express  c-kit protein (CD117) and CD34, 30% to
;50% of them are (often focally) positive  for alpha-smooth muscle actin, and
;all are negative for desmin and S100 protein.
;[441..447]:malignancy:"tumors"
;[470..480]:malignancy:"leiomyomas"
;[485..496]:malignancy:"schwannomas"
;[522..527]:malignancy:"GISTs"
;[547..552]:gene-rna:"c-kit"
;[562..567]:gene-protein:"CD117"
;[573..577]:gene-protein:"CD34"
;[632..657]:gene-protein:"alpha-smooth muscle actin"
;[684..690]:gene-protein:"desmin"
;[695..699]:gene-protein:"S100"
(SENT
  (S
    (NP-SBJ (DT:[437..440] The) (NNS:[441..447] tumors))
    (VP (VBP:[448..454] differ)
      (PP (IN:[455..459] from)
        (NP
          (NP
            (ADJP-1 (JJ:[460..468] ordinary))
            (NNS:[470..480] leiomyomas))
          (CC:[481..484] and)
          (NP
            (ADJP-1 (-NONE-:[484..484] *P*))
            (NNS:[485..496] schwannomas))))
      (PP (IN:[497..499] in)
        (NP (JJ:[500..507] several) (NNS:[508..516] respects)))
      (::[516..517] :)
      (S-ADV
        (S
          (NP-SBJ (DT:[518..521] the) (NNS:[522..527] GISTs))
          (ADVP (RB:[528..537] typically))
          (VP (VBP:[538..545] express)
            (NP
              (NP (NN:[547..552] c-kit) (NN:[553..560] protein)
                (PRN (-LRB-:[561..562] -LRB-)
                  (NP (NN:[562..567] CD117))
                  (-RRB-:[567..568] -RRB-)))
              (CC:[569..572] and)
              (NP (NN:[573..577] CD34)))))
        (,:[577..578] ,)
        (S
          (NP-SBJ
            (NP (CD:[579..581] 30) (NN:[581..582] %))
            (PP (TO:[583..585] to)
              (NP (CD:[586..588] 50) (NN:[588..589] %)))
            (PP (IN:[590..592] of)
              (NP (PRP:[593..597] them))))
          (VP (VBP:[598..601] are)
            (PRN (-LRB-:[602..603] -LRB-)
              (ADVP (RB:[603..608] often) (RB:[609..616] focally))
              (-RRB-:[616..617] -RRB-))
            (ADJP-PRD (JJ:[618..626] positive)
              (PP (IN:[628..631] for)
                (NP
                  (NML (SYM:[632..637] alpha))
                  (HYPH:[637..638] -)
                  (NML (JJ:[638..644] smooth) (NN:[645..651] muscle)
                       (NN:[652..657] actin)))))))
        (,:[657..658] ,) (CC:[659..662] and)
        (S
          (NP-SBJ (DT:[663..666] all))
          (VP (VBP:[667..670] are)
            (ADJP-PRD (JJ:[671..679] negative)
              (PP (IN:[680..683] for)
                (NP
                  (NP (NN:[684..690] desmin))
                  (CC:[691..694] and)
                  (NP (NN:[695..699] S100) (NN:[700..707] protein)))))))))
    (.:[707..708] .)))

;sentence 6 Span:710..853
;Recently, mutations in the exon 11 of the c-kit gene have been identified and
; confirmed as a molecular genetic marker for the subset of GISTs.
;[720..729]:variation-event:"mutations"
;[737..744]:variation-location:"exon 11"
;[752..757]:gene-rna:"c-kit"
;[847..852]:malignancy:"GISTs"
(SENT
  (S
    (ADVP-TMP (RB:[710..718] Recently))
    (,:[718..719] ,)
    (NP-SBJ-1
      (NP (NNS:[720..729] mutations))
      (PP-LOC (IN:[730..732] in)
        (NP
          (NP (DT:[733..736] the)
             (NN:[737..741] exon) (CD:[742..744] 11))
          (PP (IN:[745..747] of)
            (NP (DT:[748..751] the) (NN:[752..757] c-kit) (NN:[758..762] gene))))))
    (VP (VBP:[763..767] have)
      (VP (VBN:[768..772] been)
        (VP (VBN:[773..783] identified) (CC:[784..787] and)
            (VBN:[789..798] confirmed)
          (NP-1 (-NONE-:[798..798] *))
          (PP (IN:[799..801] as)
            (NP
              (NP (DT:[802..803] a) (JJ:[804..813] molecular)
                  (JJ:[814..821] genetic) (NN:[822..828] marker))
              (PP (IN:[829..832] for)
                (NP
                  (NP (DT:[833..836] the) (NN:[837..843] subset))
                  (PP (IN:[844..846] of)
                    (NP (NNS:[847..852] GISTs))))))))))
    (.:[852..853] .)))

;sentence 7 Span:854..1016
;In this report,  we describe a mesenchymal tumor removed from the pelvic
;cavity of a 52-year-old  woman, who is alive without disease 36 months after
;the surgery.
;[885..902]:malignancy:"mesenchymal tumor"
(SENT
  (S
    (PP (IN:[854..856] In)
      (NP (DT:[857..861] this) (NN:[862..868] report)))
    (,:[868..869] ,)
    (NP-SBJ (PRP:[871..873] we))
    (VP (VBP:[874..882] describe)
      (NP
        (NP (DT:[883..884] a)
           (JJ:[885..896] mesenchymal) (NN:[897..902] tumor))
        (VP (VBN:[903..910] removed)
          (NP (-NONE-:[910..910] *))
          (PP (IN:[911..915] from)
            (NP
              (NP (DT:[916..919] the) (JJ:[920..926] pelvic)
                  (NN:[927..933] cavity))
              (PP (IN:[934..936] of)
                (NP
                  (NP (DT:[937..938] a)
                    (ADJP
                      (NML (CD:[939..941] 52) (HYPH:[941..942] -)
                           (NN:[942..946] year))
                      (HYPH:[946..947] -) (JJ:[947..950] old))
                    (NN:[952..957] woman))
                  (,:[957..958] ,)
                  (SBAR
                    (WHNP-1 (WP:[959..962] who))
                    (S
                      (NP-SBJ-1 (-NONE-:[962..962] *T*))
                      (VP (VBZ:[963..965] is)
                        (ADJP-PRD (JJ:[966..971] alive)
                          (PP (IN:[972..979] without)
                            (NP (NN:[980..987] disease)))
                          (NP-TMP
                            (NP (CD:[988..990] 36) (NNS:[991..997] months))
                            (PP (IN:[998..1003] after)
                              (NP (DT:[1004..1007] the)
                                  (NN:[1008..1015] surgery)))))))))))))))
    (.:[1015..1016] .)))

;sentence 8 Span:1017..1161
;The 5-cm tumor  was densely attached to the external aspect of the urinary
;bladder but was  attached to small intestine by only filmy adhesions.
;[1026..1136]:malignancy:"tumor  was densely attached to the external aspect
;of the urinary bladder but was  attached to small intestine"
(SENT
  (S
    (NP-SBJ-1 (DT:[1017..1020] The)
      (NML (CD:[1021..1022] 5) (HYPH:[1022..1023] -) (NN:[1023..1025] cm))
      (NN:[1026..1031] tumor))
    (VP
      (VP (VBD:[1033..1036] was)
        (ADVP (RB:[1037..1044] densely))
        (VP (VBN:[1045..1053] attached)
          (NP-1 (-NONE-:[1053..1053] *))
          (PP (TO:[1054..1056] to)
            (NP
              (NP (DT:[1057..1060] the) (JJ:[1061..1069] external)
                  (NN:[1070..1076] aspect))
              (PP (IN:[1077..1079] of)
                (NP (DT:[1080..1083] the) (JJ:[1084..1091] urinary)
                    (NN:[1092..1099] bladder)))))))
      (CC:[1100..1103] but)
      (VP (VBD:[1104..1107] was)
        (VP (VBN:[1109..1117] attached)
          (NP-1 (-NONE-:[1117..1117] *))
          (PP (TO:[1118..1120] to)
            (NP (JJ:[1121..1126] small) (NN:[1127..1136] intestine)))
          (PP (IN:[1137..1139] by)
            (NP
              (ADVP (RB:[1140..1144] only))
              (JJ:[1145..1150] filmy) (NNS:[1151..1160] adhesions))))))
    (.:[1160..1161] .)))

;sentence 9 Span:1162..1299
;The tumor grossly resembled  a leiomyoma and was histologically composed of
;sheets of spindle cells with a  dense collagenous background.
;[1166..1171]:malignancy:"tumor"
;[1193..1202]:malignancy:"leiomyoma"
(SENT
  (S
    (NP-SBJ-1 (DT:[1162..1165] The) (NN:[1166..1171] tumor))
    (VP
      (VP
        (ADVP (RB:[1172..1179] grossly))
        (VBD:[1180..1189] resembled)
        (NP (DT:[1191..1192] a) (NN:[1193..1202] leiomyoma)))
      (CC:[1203..1206] and)
      (VP (VBD:[1207..1210] was)
        (ADVP (RB:[1211..1225] histologically))
        (VP (VBN:[1226..1234] composed)
          (NP-1 (-NONE-:[1234..1234] *))
          (PP (IN:[1235..1237] of)
            (NP
              (NP (NNS:[1238..1244] sheets))
              (PP (IN:[1245..1247] of)
                (NP (NN:[1248..1255] spindle) (NNS:[1256..1261] cells)))))
          (PP (IN:[1262..1266] with)
            (NP (DT:[1267..1268] a) (JJ:[1270..1275] dense)
                (JJ:[1276..1287] collagenous) (NN:[1288..1298] background))))))
    (.:[1298..1299] .)))

;sentence 10 Span:1300..1368
;The mitotic activity was low, less then 1 per 50  high-power fields.
(SENT
  (S
    (NP-SBJ (DT:[1300..1303] The) (JJ:[1304..1311] mitotic)
            (NN:[1312..1320] activity))
    (VP (VBD:[1321..1324] was)
      (ADJP-PRD (JJ:[1325..1328] low))
      (,:[1328..1329] ,)
      (NP-ADV
        (NP
          (QP (JJR:[1330..1334] less) (IN:[1335..1339] then) (CD:[1340..1341] 1)))
        (PP (IN:[1342..1345] per)
          (NP (CD:[1346..1348] 50)
            (NML (JJ:[1350..1354] high) (HYPH:[1354..1355] -)
                 (NN:[1355..1360] power))
            (NNS:[1361..1367] fields)))))
    (.:[1367..1368] .)))

;sentence 11 Span:1369..1496
;Immunohistochemically, the tumor cells were negative for  alpha-smooth muscle
;actin and desmin and positive for CD117 and CD34.
;[1396..1401]:malignancy:"tumor"
;[1427..1452]:gene-protein:"alpha-smooth muscle actin"
;[1457..1463]:gene-protein:"desmin"
;[1481..1486]:gene-protein:"CD117"
;[1491..1495]:gene-protein:"CD34"
(SENT
  (S
    (ADVP (RB:[1369..1390] Immunohistochemically))
    (,:[1390..1391] ,)
    (NP-SBJ (DT:[1392..1395] the) (NN:[1396..1401] tumor)
            (NNS:[1402..1407] cells))
    (VP (VBD:[1408..1412] were)
      (ADJP-PRD
        (ADJP (JJ:[1413..1421] negative)
          (PP (IN:[1422..1425] for)
            (NP
              (NP
                (NML (SYM:[1427..1432] alpha))
                (HYPH:[1432..1433] -)
                (NML (JJ:[1433..1439] smooth) (NN:[1440..1446] muscle)
                     (NN:[1447..1452] actin)))
              (CC:[1453..1456] and)
              (NP (NN:[1457..1463] desmin)))))
        (CC:[1464..1467] and)
        (ADJP (JJ:[1468..1476] positive)
          (PP (IN:[1477..1480] for)
            (NP (NN:[1481..1486] CD117) (CC:[1487..1490] and)
                (NN:[1491..1495] CD34))))))
    (.:[1495..1496] .)))

;sentence 12 Span:1497..1625
;Molecular  genetic analysis of the exon 11 of the c-kit gene revealed a point
;mutation in  the region commonly mutated in GISTs.
;[1532..1539]:variation-location:"exon 11"
;[1547..1552]:gene-rna:"c-kit"
;[1569..1583]:variation-type:"point mutation"
;[1619..1624]:malignancy:"GISTs"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[1497..1506] Molecular) (JJ:[1508..1515] genetic)
          (NN:[1516..1524] analysis))
      (PP (IN:[1525..1527] of)
        (NP
          (NP (DT:[1528..1531] the)
             (NN:[1532..1536] exon) (CD:[1537..1539] 11))
          (PP (IN:[1540..1542] of)
            (NP (DT:[1543..1546] the) (NN:[1547..1552] c-kit)
                (NN:[1553..1557] gene))))))
    (VP (VBD:[1558..1566] revealed)
      (NP (DT:[1567..1568] a)
         (NN:[1569..1574] point) (NN:[1575..1583] mutation))
      (PP-LOC (IN:[1584..1586] in)
        (NP
          (NP (DT:[1588..1591] the) (NN:[1592..1598] region))
          (VP (RB:[1599..1607] commonly) (VBN:[1608..1615] mutated)
            (NP (-NONE-:[1615..1615] *))
            (PP (IN:[1616..1618] in)
              (NP (NNS:[1619..1624] GISTs)))))))
    (.:[1624..1625] .)))

;sentence 13 Span:1626..1770
;This mutation substituted T for A in the  codon 557, leading to the change of
;amino acid sequence (tryptophan for  arginine) of the KIT protein.
;[1626..1639]:variation-event:"This mutation"
;[1652..1653]:variation-state-altered:"T"
;[1658..1659]:variation-state-altered:"A"
;[1668..1677]:variation-location:"codon 557"
;[1725..1735]:variation-state-altered:"tryptophan"
;[1741..1749]:variation-state-original:"arginine"
;[1758..1761]:gene-protein:"KIT"
(SENT
  (S
    (NP-SBJ (DT:[1626..1630] This) (NN:[1631..1639] mutation))
    (VP (VBD:[1640..1651] substituted)
      (NP
        (NP (NN:[1652..1653] T))
        (PP (IN:[1654..1657] for)
          (NP (NN:[1658..1659] A))))
      (PP-LOC (IN:[1660..1662] in)
        (NP (DT:[1663..1666] the)
           (NN:[1668..1673] codon) (CD:[1674..1677] 557)))
      (,:[1677..1678] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1678..1678] *))
        (VP (VBG:[1679..1686] leading)
          (PP-CLR (TO:[1687..1689] to)
            (NP
              (NP (DT:[1690..1693] the) (NN:[1694..1700] change))
              (PP (IN:[1701..1703] of)
                (NP (JJ:[1704..1709] amino) (NN:[1710..1714] acid)
                    (NN:[1715..1723] sequence)))
              (PRN (-LRB-:[1724..1725] -LRB-)
                (NP
                  (NP (NN:[1725..1735] tryptophan))
                  (PP (IN:[1736..1739] for)
                    (NP (NN:[1741..1749] arginine))))
                (-RRB-:[1749..1750] -RRB-))
              (PP (IN:[1751..1753] of)
                (NP (DT:[1754..1757] the) (NN:[1758..1761] KIT)
                    (NN:[1762..1769] protein))))))))
    (.:[1769..1770] .)))

;sentence 14 Span:1771..1924
;This case illustrates that tumors phenotypically  and genotypically similar
;to GISTs may present in sites other than the tubular  gastrointestinal
;tract.
;[1798..1804]:malignancy:"tumors"
;[1850..1855]:malignancy:"GISTs"
(SENT
  (S
    (NP-SBJ (DT:[1771..1775] This) (NN:[1776..1780] case))
    (VP (VBZ:[1781..1792] illustrates)
      (SBAR (IN:[1793..1797] that)
        (S
          (NP-SBJ
            (NP (NNS:[1798..1804] tumors))
            (ADJP
              (ADJP
                (ADJP (RB:[1805..1819] phenotypically)
                  (ADJP-1 (-NONE-:[1819..1819] *P*)))
                (CC:[1821..1824] and)
                (ADJP (RB:[1825..1838] genotypically)
                  (ADJP-1 (JJ:[1839..1846] similar))))
              (PP-2 (TO:[1847..1849] to)
                (NP (NNS:[1850..1855] GISTs)))))
          (VP (MD:[1856..1859] may)
            (VP (VB:[1860..1867] present)
              (PP-LOC (IN:[1868..1870] in)
                (NP
                  (NP (NNS:[1871..1876] sites))
                  (ADJP
                    (ADJP (JJ:[1877..1882] other))
                    (PP (IN:[1883..1887] than)
                      (NP (DT:[1888..1891] the) (JJ:[1892..1899] tubular)
                          (JJ:[1901..1917] gastrointestinal)
                          (NN:[1918..1923] tract)))))))))))
    (.:[1923..1924] .)))

;section 15 Span:1928..1973
;PMID: 10835530 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1928..1932] PMID) (::[1932..1933] :) (CD:[1934..1942] 10835530)
        (NN:[1943..1944] -LSB-) (NNP:[1944..1950] PubMed) (::[1951..1952] -)
        (NN:[1953..1960] indexed) (IN:[1961..1964] for)
        (NNP:[1965..1973] MEDLINE-RSB-)))
